Master Thesis in Translational Lung Cancer Research
We are looking for a highly motivated and curiosity-driven master student to join our lab for one year.
The students will apply cutting-edge tools (e.g. CRISPR, in vivo work with genetically engineered cancer models, transcriptomics, FACS, high-throughput automated live cell imaging and others) to explore targets for combination therapies in lung cancer. The projects will involve gene/drug screens in culture and in vivo followed by the validation and mechanistic characterization of identified candidates.
We offer:
• a challenging topic at the cutting edge of cancer research
• weekly lab meetings and journal clubs
• a stimulating and dynamic scientific environment with individual supervision
• financial support according to the guidelines of the FWF
The successful candidates should:
• be exceptionally motivated and talented
• be reliable and have very good interpersonal skills
• have B.Sc. in the field of molecular biology, cell biology, genetics, biotechnology, biochemistry or equivalent
• previous working experience in a research lab is a plus
• be proficient in English
The starting point for the Master thesis should be as soon as possible. Short listed candidates will be notified and invited for interview. Late applications may be considered until the position has been filled.
Interested candidates should send a motivation letter and CV with references to iris.urasjodl(at)meduniwien.ac.at until March 15th, 2024.
Fachgebiet
Cancer Research, Molecular and Cell Biology, Precision Medicine
Arbeitsstätte
Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna
Antrittsdatum
01. April 2024
Bewerbungsfrist
15. März 2024